5 of Last Week's Biggest Winners

These five stocks posted double-digit percentage gains.

May 11, 2014 at 12:00PM

It was a rocky week on Wall Street, with Nasdaq stocks inching lower and the Dow inching higher, but there were plenty of stocks really making some serious moves. Let's take a closer look at five of this past week's biggest scorchers.


May 9

Weekly Gain




Electronic Arts (NASDAQ:EA)



Keurig Green Mountain (NASDAQ:GMCR)



Ampio Pharmaceuticals (NYSEMKT:AMPE)






Source: Barron's.

Let's start with RadNet. The provider of MRIs and PET/CT scans has been one of this year's biggest winners, and it padded those gains after posting better-than-expected bottom-line results. Revenue came in lighter than expected as the weather kept patients away from RadNet's centers, but its deficit was half as bad as analysts were forecasting. RadNet went on to raise its full-year EBITDA and free cash flow guidance, and at least one analyst followed suit. 

Deutsche Bank raised its price target from $5 to $7 after the report. How big has 2014 been for RadNet? The stock has soared 288% so far this year.

Electronic Arts was "in the game" as the country's second largest video-game publisher posted encouraging financials results. EA's adjusted profit of $0.48 a share, more than four times the $0.11 the pros were projecting. EA credits its success to the success of Titanfall, Battlefield 4, and FIFA 14

Keurig Green Mountain came through with another blowout quarter, with sales rising 10% to top $1.1 billion. Despite rising coffee costs, margins expanded to the point where adjusted profitability climbed 16% to $1.08 a share. Analysts didn't have a clue, forecasting a profit of $0.94 a share with a mere 4% top-line gain.  

Ampio moved higher after Citigroup initiated coverage of the biotech with a "buy" rating. Ampio is in late-stage trials for Ampion, its anti-inflammatory treatment for osteoarthritis. Citigroup set a lofty price target of $21 on the shares.

Finally we have InterMune coming on after encouraging words out of Oppenheimer. The analyst thinks there's promise for InterMune's treatment for idiopathic pulmonary fibrosis, advising investors to buy the biotech ahead of the upcoming American Thoracic Society meeting.

Keep the winners coming
Imagine a company that rents a very specific and valuable piece of machinery for $41,000 per hour. (That's almost as much as the average American makes in a year!) And Warren Buffett is so confident in this company's can't-live-without-it business model, he just loaded up on 8.8 million shares. An exclusive, brand-new Motley Fool report details this company that already has over 50% market share. Just click here to discover more about this industry-leading stock, and join Buffett in his quest for a veritable landslide of profits!

Rick Munarriz owns shares of Keurig Green Mountain. The Motley Fool recommends Keurig Green Mountain and owns shares of Citigroup. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information